BHW Bayerische Heilmittel Wissenschaften GmbH is pleased to announce the opening of its new office in Frankfurt’s landmark Omniturm building. This expansion strengthens BHW’s presence in one of Germany’s most important financial and innovation hubs, complementing our company headquarters in Munich.
The new Frankfurt office serves as a strategic hub for international operations of the Heilmittel Group, enabling BHW to:
- Facilitate closer coordination with global partners, investors, and regulatory bodies based in Frankfurt’s financial district.
- Strengthen collaboration with our Canadian sister company NAH – North American Heilmittel Inc., ensuring smoother management of operations beyond Europe.
- Provide an agile base for overseeing export, distribution, and regulatory activities across the Middle East, North America, and other key global markets.
- Enhance our visibility and accessibility for business partners who regularly engage in Frankfurt’s dynamic life sciences and healthcare ecosystem.
By establishing a presence in Frankfurt, BHW creates a dual-office structure in Germany:
- Munich Headquarters – the heart of our research, strategy, and corporate governance.
- Frankfurt Omniturm Office – the gateway for financial, international, and cross-continental business operations.
This expansion reflects BHW’s and Heilmittel Group’s commitment to growth, innovation, and building strong global partnerships, while remaining firmly anchored in Bavaria’s tradition of scientific and pharmaceutical excellence.